HIGHLIGHTS
- who: Li Ma and colleagues from the Department of Cellular and Molecular Biology, Beijing TB and Thoracic Tumor Research Institution/Beijing Chest Hospital, Capital Medical University, Beimachang, Tongzhou, Beijing, China have published the article: Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma, in the Journal: (JOURNAL) of 15/06/2013
- what: The aim of this study was to examine the potential clinical values of CCNY and serum anti-CCNY autoantibodies in patients with NSCLC. The authors first examined the expression profile of CCNY in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.